When discussing brain-computer interfaces or anything with a cyberpunk-like twist, Neuralink’s first brain chip is often at the forefront. In February, 29-year-old Noland Arbaugh became the first human to undergo this trial, undergoing surgery to attach a Neuralink implant to his brain.
This implant aids individuals with quadriplegia, enabling them to control digital interfaces using only their thoughts. However, the company has now reported that several threads of this implant have “retracted” from his brain.
The device comprises 1,024 electrodes connected by 64 threads thinner than a human hair. These threads monitor the patient’s neural activity and convert it into computer commands, allowing them to use such devices with ease.
However, the retraction of threads from Noland’s brain has led to a net decrease in the number of functional electrodes. This has impacted the patient’s behavioral and psychiatric symptoms, indicating that the implant is not functioning as intended.
In an effort to address this setback, Neuralink has adjusted the recording algorithm, fine-tuned the neural-to-digital signal translation techniques, and enhanced the user experience.
Initially, Neuralink considered removing the implant, but decided against it as adjustments and enhancements neutralized the supposed threat. So, Noland is no longer at risk. He has also been optimistic about Neuralink’s potential and how it has allowed him to “play to his heart’s content.”
There are now numerous videos and livestreams posted by Neuralink, showcasing Noland playing chess and Mario Kart. In an interview with Neuralink, Noland mentioned that,
“Sure we’re still working out the kinks and stuff. But once we get this figured out, there’s no reason for the technology not to be out there.”
This situation certainly raises concerns. This brings me to the point that,
Is Neuralink Rushing to Commercialize the Brain Chip?
This malfunction marks a significant milestone in Neuralink’s journey, which began in 2016. However, it was only last year that the company obtained FDA approval after undergoing rigorous animal testing. Shortly thereafter, Noland officially became the first human trial participant.
Although the malfunction fortunately didn’t negatively impact Noland’s well-being, the idea of having pieces or threads of the Neuralink implant floating in my brain doesn’t sit well with me. While I understand the allure of technology promising a better life, is it worth risking your life for?
While this malfunction may have been a minor setback, it raises concerns about the ultimate safety of such technology. The thought of having a chip, constructed with minuscule components, lodged in my brain doesn’t sound appealing. Yes, it may offer a cyberpunk-like experience, but at what cost?
What are your thoughts? Let me know in the comments below.
0 Comments